Francis Crick Institute and Broken String Biosciences partner for ALS research The rare and fatal progressive neurodegenerative disease is estimated to affect 5,000 people in the UK
ALS Association partners with myTomorrows to improve clinical trial accessibility The fatal motor neurone disease currently does not have a cure available to treat patients